Oscar Health (OSCR) to Release Quarterly Earnings on Tuesday

Oscar Health (NYSE:OSCR - Get Free Report) is expected to release its Q4 2024 earnings data before the market opens on Tuesday, February 4th. Analysts expect Oscar Health to post earnings of ($0.55) per share and revenue of $2.47 billion for the quarter. Oscar Health has set its FY 2025 guidance at EPS.Persons interested in listening to the company's earnings conference call can do so using this link.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. On average, analysts expect Oscar Health to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Oscar Health Stock Performance

OSCR stock traded down $0.98 during trading on Thursday, reaching $14.78. 7,383,854 shares of the company's stock were exchanged, compared to its average volume of 3,866,028. The firm has a market cap of $3.65 billion, a PE ratio of -246.21, a P/E/G ratio of 0.67 and a beta of 1.73. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health has a 1-year low of $13.05 and a 1-year high of $23.79. The company's fifty day moving average price is $15.14 and its 200-day moving average price is $16.83.

Analysts Set New Price Targets

OSCR has been the topic of several research analyst reports. Bank of America cut Oscar Health from a "neutral" rating to an "underperform" rating and lowered their price target for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. Jefferies Financial Group assumed coverage on Oscar Health in a report on Tuesday, December 10th. They set an "underperform" rating and a $12.00 target price on the stock. Two analysts have rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $21.56.

Insider Activity

In related news, Director Thrive Partners Vii Growth Gp, bought 420,819 shares of the business's stock in a transaction on Tuesday, November 12th. The stock was bought at an average price of $13.68 per share, for a total transaction of $5,756,803.92. Following the transaction, the director now directly owns 5,452,081 shares in the company, valued at $74,584,468.08. This represents a 8.36 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Victoria Baltrus sold 8,078 shares of the business's stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $146,050.24. Following the transaction, the chief accounting officer now owns 146,036 shares in the company, valued at approximately $2,640,330.88. This represents a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have bought 1,055,478 shares of company stock worth $14,432,852 and have sold 103,610 shares worth $1,847,519. 25.11% of the stock is owned by company insiders.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.